Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Total Liabilities (2016 - 2025)

Skinvisible (SKVI) has disclosed Total Liabilities for 16 consecutive years, with $10.4 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 10.75% to $10.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2025, up 10.75% year-over-year, with the annual reading at $10.4 million for FY2025, 10.75% up from the prior year.
  • Total Liabilities hit $10.4 million in Q4 2025 for Skinvisible, up from $10.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $10.4 million in Q4 2025 to a low of $5.1 million in Q1 2021.
  • Historically, Total Liabilities has averaged $8.0 million across 5 years, with a median of $8.8 million in 2023.
  • Biggest five-year swings in Total Liabilities: skyrocketed 43.82% in 2023 and later increased 1.22% in 2025.
  • Year by year, Total Liabilities stood at $5.6 million in 2021, then rose by 22.05% to $6.9 million in 2022, then skyrocketed by 33.37% to $9.2 million in 2023, then rose by 2.13% to $9.4 million in 2024, then increased by 10.75% to $10.4 million in 2025.
  • Business Quant data shows Total Liabilities for SKVI at $10.4 million in Q4 2025, $10.1 million in Q3 2025, and $9.9 million in Q2 2025.